Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]

Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] was reported 17304 times

Drugs of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 AMNIOTIC FLUID INDEX INCREASED 15 0.8333
1 SWEAT TEST ABNORMAL 28 0.4118
2 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2107 0.3867
3 CYSTIC FIBROSIS HEPATIC DISEASE 8 0.3478
4 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 237 0.2654
5 CYSTIC FIBROSIS LUNG 27 0.2109
6 CYSTIC FIBROSIS RELATED DIABETES 24 0.1644
7 DISTAL INTESTINAL OBSTRUCTION SYNDROME 51 0.1513
8 VITAMIN A INCREASED 7 0.1400
9 PULMONARY FUNCTION TEST DECREASED 543 0.1239
10 CONGENITAL ABSENCE OF CRANIAL VAULT 7 0.1207
11 CYSTIC FIBROSIS GASTROINTESTINAL DISEASE 3 0.1200
12 CYSTIC FIBROSIS 565 0.1019
13 ATYPICAL MYCOBACTERIAL LOWER RESPIRATORY TRACT INFECTION 6 0.0833
14 PELVIC KIDNEY 9 0.0776
15 PULMONARY FUNCTION TEST 4 0.0714
16 ANTIBIOTIC PROPHYLAXIS 3 0.0682
17 INFECTIVE EXACERBATION OF BRONCHIECTASIS 19 0.0619
18 FORCED EXPIRATORY VOLUME DECREASED 173 0.0610
19 FOETAL MACROSOMIA 16 0.0576
20 LEFT-TO-RIGHT CARDIAC SHUNT 15 0.0508
21 FORCED EXPIRATORY VOLUME INCREASED 3 0.0508
22 FORCED EXPIRATORY VOLUME ABNORMAL 7 0.0483
23 MECONIUM ILEUS 3 0.0455
24 BRONCHOSCOPY 10 0.0422
25 PSEUDOMONAS TEST POSITIVE 33 0.0403
26 SPUTUM INCREASED 86 0.0397
27 BURKHOLDERIA CEPACIA COMPLEX INFECTION 11 0.0385
28 IMMATURE RESPIRATORY SYSTEM 6 0.0382
29 POST-TUSSIVE VOMITING 6 0.0368
30 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 18 0.0352
31 BRONCHIAL SECRETION RETENTION 41 0.0322
32 SUPERIOR VENA CAVA OCCLUSION 4 0.0315
33 RESPIRATORY SYMPTOM 89 0.0313
34 LUNG TRANSPLANT 107 0.0302
35 STENOTROPHOMONAS TEST POSITIVE 4 0.0299
36 FUNGAL DISEASE CARRIER 3 0.0297
37 RESPIRATION ABNORMAL 194 0.0281
38 INCREASED VISCOSITY OF BRONCHIAL SECRETION 17 0.0266
39 LENTICULAR OPACITIES 11 0.0252
40 LUNG INFECTION PSEUDOMONAL 14 0.0251
41 CHALAZION 16 0.0250
42 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 23 0.0248
43 ALKALOSIS HYPOCHLORAEMIC 3 0.0214
44 SINUS OPERATION 51 0.0214
45 MOTOR DEVELOPMENTAL DELAY 12 0.0208
46 ADENOIDECTOMY 8 0.0206
47 BANDAEMIA 3 0.0204
48 LIPOEDEMA 8 0.0204
49 GASTROSTOMY TUBE SITE COMPLICATION 4 0.0200
50 PSEUDOMONAS INFECTION 167 0.0195
51 BACTERIAL DISEASE CARRIER 14 0.0192
52 SINUS POLYP 11 0.0191
53 INCREASED BRONCHIAL SECRETION 47 0.0184
54 NEUROPSYCHOLOGICAL SYMPTOMS 10 0.0166
55 ELECTIVE SURGERY 3 0.0163
56 DEFIANT BEHAVIOUR 5 0.0162
57 RESPIRATORY TRACT INFECTION BACTERIAL 8 0.0161
58 LOWER RESPIRATORY TRACT INFECTION VIRAL 8 0.0158
59 PNEUMONIA PSEUDOMONAL 24 0.0156
60 OESOPHAGEAL ACHALASIA 10 0.0155
61 PULMONARY FUNCTION TEST ABNORMAL 24 0.0154
62 GRANULOCYTOSIS 3 0.0153
63 HOSPITALISATION 2340 0.0152
64 RESPIRATORY TRACT HAEMORRHAGE 9 0.0151
65 INTENSIVE CARE 21 0.0148
66 VIRAL RASH 6 0.0147
67 MYCOBACTERIUM TEST POSITIVE 3 0.0146
68 SPORTS INJURY 5 0.0145
69 CROUP INFECTIOUS 11 0.0140
70 PROTHROMBIN TIME RATIO INCREASED 3 0.0138
71 ABSCESS RUPTURE 5 0.0133
72 DEVICE RELATED THROMBOSIS 13 0.0132
73 CATARACT SUBCAPSULAR 8 0.0131
74 LOWER RESPIRATORY TRACT INFECTION FUNGAL 5 0.0129
75 OESOPHAGEAL ADENOCARCINOMA 6 0.0126
76 MYCOBACTERIUM ABSCESSUS INFECTION 9 0.0126
77 STAPHYLOCOCCUS TEST POSITIVE 25 0.0118
78 BUTTERFLY RASH 12 0.0118
79 HEMIPLEGIC MIGRAINE 4 0.0118
80 PNEUMOTHORAX SPONTANEOUS 8 0.0118
81 PNEUMONIA STAPHYLOCOCCAL 21 0.0106
82 NASAL INFLAMMATION 11 0.0104
83 LUNG INFECTION 161 0.0104
84 GASTROSTOMY 16 0.0103
85 RESPIRATORY TRACT INFECTION VIRAL 24 0.0103
86 TONSILLECTOMY 17 0.0102
87 PANCREATITIS RELAPSING 8 0.0098
88 STEATORRHOEA 26 0.0097
89 BRONCHIAL HAEMORRHAGE 3 0.0096
90 RESPIRATORY TRACT IRRITATION 10 0.0096
91 RHINOVIRUS INFECTION 37 0.0095
92 CORONA VIRUS INFECTION 4 0.0093
93 THREATENED LABOUR 4 0.0093
94 HAEMOPTYSIS 258 0.0092
95 ANTIBIOTIC THERAPY 9 0.0092
96 HAEMOPHILUS INFECTION 9 0.0092
97 PANCREATIC ATROPHY 4 0.0092
98 CHOLESTASIS OF PREGNANCY 4 0.0087
99 ANION GAP DECREASED 3 0.0086
100 CENTRAL VENOUS CATHETER REMOVAL 4 0.0085
101 LIVER FUNCTION TEST INCREASED 183 0.0085
102 DERMATITIS DIAPER 6 0.0085
103 TRANSPLANT 20 0.0084
104 HUMAN RHINOVIRUS TEST POSITIVE 3 0.0080
105 EMERGENCY CARE 24 0.0079
106 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 3 0.0079
107 PARAINFLUENZAE VIRUS INFECTION 12 0.0079
108 TRACHEOBRONCHITIS 6 0.0078
109 OPPOSITIONAL DEFIANT DISORDER 3 0.0076
110 DRUG SCREEN FALSE POSITIVE 21 0.0076
111 STENOTROPHOMONAS INFECTION 10 0.0074
112 BEHAVIOUR DISORDER 37 0.0068
113 OTITIS MEDIA ACUTE 5 0.0068
114 PULMONARY HAEMORRHAGE 53 0.0068
115 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 5 0.0065
116 BRONCHIAL OBSTRUCTION 9 0.0064
117 MYCOBACTERIAL INFECTION 11 0.0064
118 LOWER RESPIRATORY TRACT INFECTION 289 0.0063
119 VIRAL UPPER RESPIRATORY TRACT INFECTION 30 0.0063
120 VITAMIN B12 INCREASED 5 0.0063
121 INFECTIOUS MONONUCLEOSIS 14 0.0062
122 PANCREATIC FAILURE 11 0.0062
123 LUNG ABSCESS 13 0.0062
124 EPIDIDYMITIS 7 0.0060
125 ORTHOPAEDIC PROCEDURE 3 0.0058
126 ENTEROVIRUS INFECTION 5 0.0058
127 BRONCHIECTASIS 39 0.0058
128 SELF-DESTRUCTIVE BEHAVIOUR 5 0.0057
129 BRONCHIAL WALL THICKENING 4 0.0056
130 TONSILLAR DISORDER 6 0.0053
131 IDIOPATHIC INTRACRANIAL HYPERTENSION 12 0.0053
132 CENTRAL VENOUS CATHETERISATION 16 0.0053
133 PNEUMOTHORAX 84 0.0053
134 COMPLICATION OF PREGNANCY 4 0.0053
135 INTUSSUSCEPTION 5 0.0052
136 ACUTE SINUSITIS 9 0.0052
137 DISCOLOURED VOMIT 5 0.0052
138 CREATINE KINASE INCREASED 4 0.0052
139 PORTAL HYPERTENSION 16 0.0052
140 CARBON DIOXIDE INCREASED 7 0.0051
141 DISTURBANCE IN SOCIAL BEHAVIOUR 12 0.0051
142 H1N1 INFLUENZA 7 0.0050
143 PHARYNGITIS STREPTOCOCCAL 53 0.0049
144 NASAL POLYPS 24 0.0049
145 MEDICAL DEVICE SITE INFECTION 3 0.0048
146 DRUG LEVEL CHANGED 3 0.0048
147 SINUSITIS BACTERIAL 5 0.0047
148 PNEUMONIA VIRAL 15 0.0047
149 FOOD REFUSAL 4 0.0046
150 LUNG TRANSPLANT REJECTION 3 0.0045
151 BRONCHITIS VIRAL 3 0.0045
152 PULMONARY PAIN 13 0.0044
153 INFECTION 640 0.0044
154 GASTROINTESTINAL TUBE INSERTION 11 0.0044
155 RESPIRATORY SYNCYTIAL VIRUS INFECTION 38 0.0044
156 CHEST DISCOMFORT 437 0.0043
157 MEDICAL PROCEDURE 7 0.0042
158 PAPILLOEDEMA 19 0.0042
159 SPEECH DISORDER DEVELOPMENTAL 12 0.0042
160 DISEASE COMPLICATION 19 0.0041
161 ABNORMAL FAECES 34 0.0041
162 LIVER TRANSPLANT 15 0.0041
163 UNDERWEIGHT 8 0.0041
164 SPUTUM RETENTION 4 0.0040
165 INTERCEPTED DRUG DISPENSING ERROR 6 0.0040
166 METAPNEUMOVIRUS INFECTION 3 0.0038
167 EXERCISE TOLERANCE DECREASED 22 0.0038
168 SINUS DISORDER 75 0.0038
169 GASTROENTERITIS NOROVIRUS 5 0.0038
170 POLYPECTOMY 3 0.0037
171 GASTROINTESTINAL OBSTRUCTION 9 0.0037
172 CHRONIC SINUSITIS 14 0.0037
173 HEPATIC NECROSIS 14 0.0037
174 VIRAL INFECTION 123 0.0037
175 OESOPHAGEAL VARICES HAEMORRHAGE 8 0.0037
176 HAND-FOOT-AND-MOUTH DISEASE 3 0.0036
177 ATTENTION DEFICIT HYPERACTIVITY DISORDER 15 0.0036
178 STAPHYLOCOCCAL INFECTION 117 0.0035
179 HEPATIC CYTOLYSIS 45 0.0035
180 LOWER RESPIRATORY TRACT CONGESTION 6 0.0035
181 PRODUCTIVE COUGH 168 0.0035
182 HEPATIC FIBROSIS 12 0.0035
183 POLYMENORRHOEA 12 0.0035
184 EAR INFECTION 92 0.0035
185 DEPRESSIVE SYMPTOM 12 0.0034
186 MYCOBACTERIUM AVIUM COMPLEX INFECTION 9 0.0033
187 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 4 0.0033
188 RECTAL PROLAPSE 4 0.0033
189 HYPOGLYCAEMIC SEIZURE 3 0.0033
190 FEBRILE CONVULSION 4 0.0033
191 BLOOD ALKALINE PHOSPHATASE INCREASED 81 0.0033
192 BODY TEMPERATURE ABNORMAL 6 0.0033
193 BRONCHOSPASM 46 0.0032
194 INFLUENZA 358 0.0032
195 PROTHROMBIN LEVEL DECREASED 3 0.0032
196 HEPATIC INFECTION 4 0.0031
197 CANCER SURGERY 3 0.0031
198 TOTAL LUNG CAPACITY DECREASED 5 0.0031
199 OVARIAN CYST RUPTURED 4 0.0031
200 ALANINE AMINOTRANSFERASE INCREASED 190 0.0031
201 ASPARTATE AMINOTRANSFERASE INCREASED 164 0.0031
202 ASPERGILLUS INFECTION 20 0.0030
203 WISDOM TEETH REMOVAL 4 0.0030
204 HEPATIC ENZYME ABNORMAL 15 0.0030
205 CHANGE OF BOWEL HABIT 6 0.0029
206 WEIGHT ABNORMAL 7 0.0029
207 NASAL DISCHARGE DISCOLOURATION 4 0.0029
208 INTESTINAL OBSTRUCTION 109 0.0029
209 INVESTIGATION 9 0.0029
210 SLEEP TERROR 12 0.0028
211 ATYPICAL MYCOBACTERIAL INFECTION 4 0.0028
212 APPENDIX DISORDER 4 0.0028
213 GASTROENTERITIS VIRAL 51 0.0028
214 ANAEMIA MACROCYTIC 6 0.0028
215 TREATMENT NONCOMPLIANCE 153 0.0028
216 GAMMA-GLUTAMYLTRANSFERASE INCREASED 61 0.0027
217 HYPERTRANSAMINASAEMIA 19 0.0027
218 FAECES PALE 6 0.0027
219 STREPTOCOCCAL INFECTION 15 0.0027
220 BACTERIAL TEST POSITIVE 6 0.0027
221 CHOLANGIOCARCINOMA 4 0.0027
222 LUNG DISORDER 131 0.0027
223 STEROID DIABETES 4 0.0027
224 HYPERCAPNIA 8 0.0027
225 MECHANICAL VENTILATION 5 0.0026
226 PANCREATIC CYST 5 0.0026
227 PANCREATITIS CHRONIC 6 0.0025
228 INTESTINAL OPERATION 4 0.0025
229 MYOPIA 6 0.0025
230 ESCHERICHIA TEST POSITIVE 3 0.0025
231 FAILURE TO THRIVE 13 0.0025
232 TONSILLITIS 13 0.0025
233 CHRONIC RESPIRATORY FAILURE 3 0.0025
234 PANCREATIC DISORDER 12 0.0024
235 SPUTUM DISCOLOURED 23 0.0024
236 POLYCYTHAEMIA 5 0.0024
237 INSURANCE ISSUE 37 0.0024
238 IGA NEPHROPATHY 4 0.0024
239 RALES 14 0.0024
240 IMPULSIVE BEHAVIOUR 9 0.0024
241 GASTRIC INFECTION 9 0.0024
242 INTRACRANIAL PRESSURE INCREASED 13 0.0023
243 TENSION HEADACHE 10 0.0023
244 SINUSITIS 238 0.0023
245 VENTRICULAR DYSFUNCTION 6 0.0023
246 COUGH 640 0.0023
247 PNEUMONIA FUNGAL 9 0.0023
248 HYPOVITAMINOSIS 3 0.0023
249 SECRETION DISCHARGE 28 0.0022
250 INTRA-ABDOMINAL FLUID COLLECTION 4 0.0022
251 BRAIN FOG 35 0.0022
252 RESPIRATORY DISORDER 66 0.0022
253 BACTERIAL INFECTION 41 0.0022
254 HYPOVENTILATION 7 0.0021
255 VITILIGO 5 0.0021
256 MOOD ALTERED 58 0.0021
257 PARANASAL SINUS DISCOMFORT 8 0.0021
258 VOLVULUS 5 0.0021
259 EXPOSURE DURING PREGNANCY 131 0.0021
260 NASOPHARYNGITIS 384 0.0021
261 HORDEOLUM 9 0.0021
262 PAINFUL RESPIRATION 5 0.0021
263 ADENOVIRUS INFECTION 6 0.0021
264 BRONCHITIS CHRONIC 5 0.0020
265 SINUS HEADACHE 12 0.0020
266 RESPIRATORY TRACT CONGESTION 32 0.0020
267 ATYPICAL PNEUMONIA 6 0.0020
268 RESPIRATORY TRACT INFECTION 52 0.0020
269 HEPATIC ENZYME INCREASED 136 0.0020
270 VASCULAR DEVICE INFECTION 9 0.0020
271 ASTIGMATISM 3 0.0020
272 PERSONALITY CHANGE 18 0.0019
273 PANCREATITIS 101 0.0019
274 PULMONARY CONGESTION 25 0.0019
275 INAPPROPRIATE AFFECT 3 0.0019
276 TESTICULAR PAIN 6 0.0019
277 MENTAL DISORDER 81 0.0019
278 LIP BLISTER 5 0.0018
279 TYPE 1 DIABETES MELLITUS 11 0.0018
280 OTITIS MEDIA 6 0.0018
281 BRONCHOPULMONARY ASPERGILLOSIS 14 0.0018
282 EDUCATIONAL PROBLEM 3 0.0018
283 DEPRESSED MOOD 95 0.0018
284 UPPER RESPIRATORY TRACT INFECTION 83 0.0018
285 MOOD SWINGS 57 0.0018
286 ENDOTRACHEAL INTUBATION 5 0.0018
287 AFFECTIVE DISORDER 14 0.0018
288 GASTROINTESTINAL DISORDER 159 0.0018
289 BLOOD CREATINE PHOSPHOKINASE INCREASED 51 0.0018
290 INITIAL INSOMNIA 18 0.0018
291 BLOOD CHLORIDE INCREASED 3 0.0017
292 HEPATOMEGALY 17 0.0017
293 PNEUMONIA 558 0.0017
294 BREAST CYST 3 0.0017
295 APPENDICECTOMY 6 0.0017
296 LIVER TRANSPLANT REJECTION 3 0.0017
297 CHOLECYSTECTOMY 19 0.0017
298 SURGERY 97 0.0017
299 SINUS CONGESTION 22 0.0016
300 ACUTE PSYCHOSIS 4 0.0016
301 SUFFOCATION FEELING 4 0.0016
302 ACUTE RESPIRATORY FAILURE 31 0.0016
303 INFREQUENT BOWEL MOVEMENTS 4 0.0016
304 ADENOCARCINOMA OF COLON 3 0.0016
305 ANGER 54 0.0016
306 HEPATIC CIRRHOSIS 30 0.0016
307 BRAIN ABSCESS 4 0.0016
308 RHINITIS ALLERGIC 7 0.0016
309 PARANASAL SINUS HYPERSECRETION 6 0.0016
310 BILE DUCT STONE 5 0.0016
311 AFFECT LABILITY 15 0.0016
312 CONCUSSION 12 0.0015
313 HERNIA REPAIR 4 0.0015
314 FLATULENCE 87 0.0015
315 ABORTION SPONTANEOUS 61 0.0015
316 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
317 BLOOD BILIRUBIN INCREASED 41 0.0015
318 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 5 0.0015
319 ANXIETY DISORDER 5 0.0015
320 DEVICE RELATED SEPSIS 3 0.0015
321 BREAST SWELLING 4 0.0015
322 TRANSAMINASES INCREASED 33 0.0015
323 PLEURITIC PAIN 4 0.0014
324 MENSTRUAL DISORDER 12 0.0014
325 HEPATITIS 37 0.0014
326 RASH MORBILLIFORM 4 0.0014
327 HORMONE LEVEL ABNORMAL 7 0.0014
328 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
329 SCREAMING 9 0.0014
330 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
331 BLOOD TESTOSTERONE INCREASED 3 0.0014
332 JAW FRACTURE 3 0.0014
333 RENAL TRANSPLANT 5 0.0014
334 AGGRESSION 69 0.0014
335 DRUG-INDUCED LIVER INJURY 43 0.0014
336 CLOSTRIDIUM TEST POSITIVE 3 0.0014
337 LIVER DISORDER 60 0.0014
338 FUNGAL INFECTION 45 0.0013
339 PARESIS 3 0.0013
340 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
341 NASAL CONGESTION 78 0.0013
342 PSYCHOMOTOR HYPERACTIVITY 22 0.0013
343 ABDOMINAL PAIN UPPER 272 0.0013
344 RESPIRATORY FAILURE 96 0.0013
345 WHEEZING 78 0.0013
346 PNEUMONIA BACTERIAL 12 0.0013
347 DYSPNOEA 740 0.0013
348 VITAMIN D DECREASED 11 0.0013
349 BILIRUBIN CONJUGATED INCREASED 3 0.0013
350 HAND FRACTURE 9 0.0013
351 IDIOPATHIC PULMONARY FIBROSIS 5 0.0013
352 INFLUENZA LIKE ILLNESS 104 0.0013
353 DRUG DOSE OMISSION 208 0.0013
354 EXPOSURE VIA BREAST MILK 5 0.0013
355 OXYGEN CONSUMPTION INCREASED 3 0.0013
356 HYPERBILIRUBINAEMIA 13 0.0013
357 OBSTRUCTION 5 0.0013
358 PREMATURE RUPTURE OF MEMBRANES 3 0.0012
359 BLOOD IMMUNOGLOBULIN E INCREASED 3 0.0012
360 POLYP 8 0.0012
361 BREAST ENLARGEMENT 4 0.0012
362 NEPHROLITHIASIS 56 0.0012
363 BREATH SOUNDS ABNORMAL 6 0.0012
364 DENTAL OPERATION 3 0.0012
365 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
366 SOCIAL PROBLEM 5 0.0012
367 UPPER LIMB FRACTURE 24 0.0012
368 DRUG INTERACTION 191 0.0012
369 LIVER FUNCTION TEST ABNORMAL 35 0.0012
370 HEPATOCELLULAR INJURY 17 0.0012
371 OXYGEN SATURATION DECREASED 67 0.0012
372 SELF-INJURIOUS IDEATION 5 0.0012
373 DIABETIC COMPLICATION 3 0.0012
374 PERIPHERAL VASCULAR DISORDER 6 0.0012
375 BLOOD CHLORIDE DECREASED 3 0.0012
376 ABNORMAL BEHAVIOUR 46 0.0012
377 CATHETER SITE PAIN 3 0.0012
378 HEPATITIS TOXIC 3 0.0012
379 PRODUCT DOSE OMISSION 75 0.0011
380 DRUG LEVEL INCREASED 19 0.0011
381 EXFOLIATIVE RASH 3 0.0011
382 SMALL INTESTINAL OBSTRUCTION 14 0.0011
383 EMOTIONAL DISORDER 35 0.0011
384 PHARYNGITIS 14 0.0011
385 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
386 MYOSITIS 10 0.0011
387 SUICIDAL IDEATION 102 0.0011
388 RHINORRHOEA 72 0.0011
389 MALAISE 487 0.0011
390 LUPUS-LIKE SYNDROME 10 0.0011
391 TIC 6 0.0011
392 HYPOMENORRHOEA 3 0.0011
393 EAR DISORDER 5 0.0011
394 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
395 IRRITABILITY 65 0.0011
396 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
397 CONJUNCTIVITIS 20 0.0011
398 PRODUCT DISTRIBUTION ISSUE 10 0.0011
399 ATRIAL SEPTAL DEFECT 9 0.0011
400 ROSACEA 5 0.0011
401 CHOLECYSTITIS ACUTE 6 0.0011
402 PRE-ECLAMPSIA 5 0.0011
403 ENDOMETRIOSIS 5 0.0010
404 SKIN ATROPHY 6 0.0010
405 MUSCULOSKELETAL CHEST PAIN 16 0.0010
406 MANIA 17 0.0010
407 HEPATOTOXICITY 23 0.0010
408 EPIGASTRIC DISCOMFORT 4 0.0010
409 MENORRHAGIA 20 0.0010
410 MUCOUS STOOLS 5 0.0010
411 CREPITATIONS 3 0.0010
412 BRAIN HERNIATION 3 0.0010
413 APHONIA 14 0.0010
414 HYPERPHAGIA 4 0.0010
415 BLEPHARITIS 4 0.0010
416 ACNE CYSTIC 3 0.0010
417 DENTAL CARIES 11 0.0010
418 INTENTIONAL SELF-INJURY 20 0.0010
419 SEASONAL ALLERGY 14 0.0010
420 EATING DISORDER 21 0.0010
421 MALNUTRITION 11 0.0010
422 OROPHARYNGEAL PAIN 91 0.0010
423 PRODUCT SUPPLY ISSUE 7 0.0010
424 FIBROSIS 3 0.0010
425 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
426 HYPOGLYCAEMIA 47 0.0010
427 HEPATIC STEATOSIS 18 0.0010
428 RASH GENERALISED 25 0.0010
429 HEPATIC ENCEPHALOPATHY 9 0.0010
430 HEPATIC PAIN 4 0.0009
431 CRYING 34 0.0009
432 GASTROINTESTINAL MOTILITY DISORDER 5 0.0009
433 FOOD POISONING 5 0.0009
434 TEARFULNESS 4 0.0009
435 ILL-DEFINED DISORDER 56 0.0009
436 WEIGHT DECREASED 257 0.0009
437 THERAPY CHANGE 9 0.0009
438 BOWEL MOVEMENT IRREGULARITY 7 0.0009
439 FAECALOMA 5 0.0009
440 DEAFNESS NEUROSENSORY 3 0.0009
441 NEAR DEATH EXPERIENCE 3 0.0009
442 CORONAVIRUS INFECTION 6 0.0009
443 LYME DISEASE 3 0.0009
444 THERAPY CESSATION 46 0.0009
445 SLEEP DISORDER 63 0.0009
446 RASH PAPULAR 20 0.0009
447 PANCREATITIS ACUTE 20 0.0009
448 IRON DEFICIENCY 4 0.0009
449 GENERALISED OEDEMA 11 0.0009
450 FREQUENT BOWEL MOVEMENTS 24 0.0009
451 PREMATURE LABOUR 5 0.0009
452 ABDOMINAL DISCOMFORT 146 0.0009
453 PERICARDIAL EFFUSION 20 0.0009
454 GENERAL PHYSICAL HEALTH DETERIORATION 100 0.0009
455 RENAL FUNCTION TEST ABNORMAL 4 0.0009
456 RASH MACULO-PAPULAR 19 0.0009
457 BRONCHIOLITIS 3 0.0009
458 LOGORRHOEA 3 0.0009
459 DECREASED INTEREST 5 0.0008
460 ABDOMINAL PAIN 197 0.0008
461 RHABDOMYOLYSIS 35 0.0008
462 RESPIRATORY DISTRESS 23 0.0008
463 BODY TEMPERATURE INCREASED 17 0.0008
464 DYSMENORRHOEA 11 0.0008
465 CANDIDA INFECTION 14 0.0008
466 RASH VESICULAR 4 0.0008
467 DEPRESSION 188 0.0008
468 WEIGHT INCREASED 185 0.0008
469 CATARACT 49 0.0008
470 EPILEPSY 25 0.0008
471 CONSTIPATION 178 0.0008
472 HOSPICE CARE 8 0.0008
473 CHEST PAIN 150 0.0008
474 HYPERVOLAEMIA 4 0.0008
475 MUSCLE STRAIN 7 0.0008
476 ILLNESS 83 0.0008
477 ACUTE HEPATIC FAILURE 11 0.0008
478 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
479 PROTEIN TOTAL DECREASED 3 0.0008
480 DERMATITIS ALLERGIC 10 0.0008
481 PYREXIA 274 0.0008
482 CLAVICLE FRACTURE 3 0.0008
483 GASTROINTESTINAL INFECTION 7 0.0008
484 GALACTORRHOEA 5 0.0008
485 DYSPEPSIA 76 0.0008
486 FAECES HARD 3 0.0008
487 CARDIOPULMONARY FAILURE 3 0.0008
488 HEPATITIS ACUTE 5 0.0008
489 HYPERSOMNIA 22 0.0008
490 MALABSORPTION 4 0.0008
491 KIDNEY INFECTION 15 0.0008
492 ANXIETY 217 0.0008
493 ASTHMA 86 0.0008
494 GASTRIC DISORDER 26 0.0008
495 SARS-COV-2 TEST POSITIVE 10 0.0008
496 APATHY 11 0.0008
497 PREMATURE DELIVERY 12 0.0008
498 WRIST FRACTURE 9 0.0008
499 RHINITIS 6 0.0007
500 ABORTION INDUCED 7 0.0007
501 AMENORRHOEA 13 0.0007
502 GALLBLADDER OPERATION 3 0.0007
503 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
504 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
505 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
506 SPINAL OPERATION 9 0.0007
507 CHOLESTASIS 14 0.0007
508 DECREASED APPETITE 169 0.0007
509 ATELECTASIS 7 0.0007
510 HERNIA 14 0.0007
511 HUNGER 10 0.0007
512 DEFAECATION URGENCY 5 0.0007
513 HALLUCINATIONS, MIXED 3 0.0007
514 MIGRAINE 68 0.0007
515 MENSTRUATION IRREGULAR 19 0.0007
516 SUICIDE ATTEMPT 43 0.0007
517 MUSCLE FATIGUE 3 0.0007
518 MATERNAL EXPOSURE DURING PREGNANCY 63 0.0007
519 THERMAL BURN 5 0.0007
520 HEPATIC FAILURE 21 0.0007
521 MIDDLE INSOMNIA 13 0.0007
522 OCULAR ICTERUS 3 0.0007
523 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
524 DRUG LEVEL DECREASED 7 0.0007
525 FAECES SOFT 5 0.0007
526 MAJOR DEPRESSION 5 0.0007
527 HYPERTRIGLYCERIDAEMIA 4 0.0007
528 GASTROOESOPHAGEAL REFLUX DISEASE 55 0.0007
529 SPLENOMEGALY 8 0.0007
530 HYPOXIA 24 0.0007
531 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
532 CHOLECYSTITIS 8 0.0007
533 WEIGHT FLUCTUATION 7 0.0007
534 PROTHROMBIN TIME PROLONGED 4 0.0007
535 BLOOD GLUCOSE DECREASED 32 0.0007
536 CHROMATURIA 15 0.0007
537 BRONCHITIS 49 0.0007
538 PERICARDITIS 11 0.0007
539 TINNITUS 30 0.0007
540 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
541 NIGHT SWEATS 21 0.0007
542 EYE OPERATION 3 0.0007
543 CHRONIC MYELOID LEUKAEMIA 3 0.0006
544 DEVICE RELATED INFECTION 10 0.0006
545 ANKLE FRACTURE 10 0.0006
546 ERYTHEMA MULTIFORME 6 0.0006
547 EXTRA DOSE ADMINISTERED 26 0.0006
548 NASAL DRYNESS 4 0.0006
549 LYMPHOPENIA 9 0.0006
550 BRAIN OEDEMA 8 0.0006
551 FOOT FRACTURE 12 0.0006
552 HEADACHE 396 0.0006
553 GESTATIONAL DIABETES 3 0.0006
554 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
555 INCREASED APPETITE 12 0.0006
556 LIMB OPERATION 3 0.0006
557 FRUSTRATION TOLERANCE DECREASED 5 0.0006
558 HYPERPROLACTINAEMIA 4 0.0006
559 GALLBLADDER DISORDER 11 0.0006
560 INCORRECT DOSAGE ADMINISTERED 3 0.0006
561 CHOLELITHIASIS 20 0.0006
562 RASH PRURITIC 33 0.0006
563 ORAL CANDIDIASIS 8 0.0006
564 NIGHTMARE 21 0.0006
565 LIGAMENT SPRAIN 6 0.0006
566 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
567 ABDOMINAL DISTENSION 63 0.0006
568 HYPERNATRAEMIA 3 0.0006
569 OVARIAN CYST 6 0.0006
570 FAECES DISCOLOURED 13 0.0006
571 TERMINAL STATE 4 0.0006
572 BLOOD GLUCOSE ABNORMAL 11 0.0006
573 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
574 FEEDING DISORDER 12 0.0006
575 TACHYPNOEA 8 0.0006
576 AMMONIA INCREASED 3 0.0006
577 PETIT MAL EPILEPSY 3 0.0006
578 VOMITING 276 0.0006
579 METRORRHAGIA 10 0.0006
580 INCREASED UPPER AIRWAY SECRETION 3 0.0006
581 THROAT IRRITATION 26 0.0006
582 DISTURBANCE IN ATTENTION 31 0.0006
583 LETHARGY 33 0.0006
584 AGITATION 42 0.0006
585 LIVER INJURY 14 0.0006
586 DRUG ERUPTION 10 0.0006
587 RESPIRATORY RATE INCREASED 5 0.0006
588 BREAST PAIN 6 0.0006
589 INTENTIONAL DOSE OMISSION 16 0.0006
590 HEAVY MENSTRUAL BLEEDING 5 0.0006
591 OROPHARYNGEAL DISCOMFORT 5 0.0006
592 VISUAL FIELD DEFECT 4 0.0006
593 PULMONARY THROMBOSIS 6 0.0005
594 GASTROENTERITIS 8 0.0005
595 INTENTIONAL UNDERDOSE 4 0.0005
596 GASTROINTESTINAL PAIN 6 0.0005
597 RETINAL DETACHMENT 5 0.0005
598 HEART RATE ABNORMAL 3 0.0005
599 DIABETES MELLITUS 41 0.0005
600 HEAD INJURY 17 0.0005
601 RENAL DISORDER 25 0.0005
602 OCULAR DISCOMFORT 6 0.0005
603 EYE INFECTION 6 0.0005
604 BLOOD SODIUM DECREASED 10 0.0005
605 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
606 ACIDOSIS 4 0.0005
607 PROCEDURAL COMPLICATION 4 0.0005
608 EAR PAIN 10 0.0005
609 IMPAIRED GASTRIC EMPTYING 7 0.0005
610 DIARRHOEA 331 0.0005
611 EPISTAXIS 38 0.0005
612 PLEURISY 3 0.0005
613 DYSPNOEA EXERTIONAL 19 0.0005
614 ULCER 8 0.0005
615 ACCIDENT 6 0.0005
616 DRY EYE 25 0.0005
617 SALIVARY HYPERSECRETION 5 0.0005
618 PREMATURE BABY 15 0.0005
619 HEPATITIS CHOLESTATIC 3 0.0005
620 DEAFNESS 13 0.0005
621 DYSPHONIA 29 0.0005
622 C-REACTIVE PROTEIN INCREASED 18 0.0005
623 GASTRITIS 13 0.0005
624 HYPOTHERMIA 5 0.0005
625 PANIC ATTACK 18 0.0005
626 DIALYSIS 7 0.0005
627 DERMATITIS ACNEIFORM 3 0.0005
628 HELICOBACTER INFECTION 5 0.0005
629 RASH 210 0.0005
630 THROAT TIGHTNESS 13 0.0005
631 ROAD TRAFFIC ACCIDENT 20 0.0005
632 BLOOD UREA INCREASED 8 0.0005
633 MUSCLE ATROPHY 6 0.0005
634 URTICARIA 79 0.0005
635 CIRCULATORY COLLAPSE 8 0.0005
636 HYPOPHAGIA 12 0.0005
637 RETCHING 10 0.0005
638 DRUG DISPENSING ERROR 7 0.0005
639 BLOOD GLUCOSE FLUCTUATION 5 0.0005
640 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
641 HEAD DISCOMFORT 8 0.0005
642 FATIGUE 350 0.0004
643 ACNE 34 0.0004
644 THIRST 8 0.0004
645 SNEEZING 10 0.0004
646 CONDITION AGGRAVATED 135 0.0004
647 ASCITES 13 0.0004
648 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 3 0.0004
649 ABNORMAL LOSS OF WEIGHT 3 0.0004
650 IMPAIRED DRIVING ABILITY 5 0.0004
651 RASH ERYTHEMATOUS 21 0.0004
652 RIB FRACTURE 9 0.0004
653 BRAIN NEOPLASM 4 0.0004
654 SEIZURE 50 0.0004
655 AUTOIMMUNE HEPATITIS 3 0.0004
656 RASH MACULAR 15 0.0004
657 APPENDICITIS 4 0.0004
658 INSOMNIA 112 0.0004
659 MUCOSAL INFLAMMATION 11 0.0004
660 POOR QUALITY SLEEP 9 0.0004
661 POST PROCEDURAL COMPLICATION 8 0.0004
662 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
663 SWELLING FACE 27 0.0004
664 ADRENAL INSUFFICIENCY 5 0.0004
665 FEELING ABNORMAL 98 0.0004
666 KNEE OPERATION 4 0.0004
667 PARANOIA 7 0.0004
668 INABILITY TO AFFORD MEDICATION 4 0.0004
669 TOOTH EXTRACTION 5 0.0004
670 BRAIN INJURY 4 0.0004
671 PAROSMIA 3 0.0004
672 VAGINAL DISCHARGE 4 0.0004
673 FOETAL EXPOSURE DURING PREGNANCY 32 0.0004
674 DRY THROAT 4 0.0004
675 HYPERTHERMIA 3 0.0004
676 SLUGGISHNESS 4 0.0004
677 NAUSEA 310 0.0004
678 LIPASE INCREASED 3 0.0004
679 COVID-19 68 0.0004
680 LEUKOCYTOSIS 7 0.0004
681 HYPERGLYCAEMIA 14 0.0004
682 MULTIPLE ALLERGIES 3 0.0004
683 CYANOSIS 6 0.0004
684 BEDRIDDEN 5 0.0004
685 HAEMATURIA 13 0.0004
686 IMMUNE SYSTEM DISORDER 5 0.0004
687 MEMORY IMPAIRMENT 52 0.0004
688 HALLUCINATION, AUDITORY 6 0.0004
689 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
690 DEATH 323 0.0004
691 IMPAIRED WORK ABILITY 8 0.0004
692 QUALITY OF LIFE DECREASED 5 0.0004
693 DECREASED ACTIVITY 4 0.0004
694 PRODUCT TASTE ABNORMAL 5 0.0004
695 LIMB INJURY 10 0.0004
696 BIPOLAR DISORDER 4 0.0004
697 PALLOR 10 0.0004
698 PRODUCT DISPENSING ERROR 8 0.0004
699 FEELING JITTERY 7 0.0004
700 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
701 PHOTOSENSITIVITY REACTION 6 0.0004
702 EMBOLISM 3 0.0004
703 DEHYDRATION 48 0.0004
704 HYPERHIDROSIS 46 0.0004
705 VISUAL IMPAIRMENT 44 0.0004
706 ALOPECIA 69 0.0004
707 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
708 MUSCULOSKELETAL DISCOMFORT 6 0.0003
709 MUSCLE TWITCHING 8 0.0003
710 MYALGIA 59 0.0003
711 HYSTERECTOMY 3 0.0003
712 HYPERSENSITIVITY 64 0.0003
713 EOSINOPHILIA 6 0.0003
714 SEPSIS 38 0.0003
715 COVID-19 PNEUMONIA 4 0.0003
716 BLOOD IRON DECREASED 4 0.0003
717 HOT FLUSH 25 0.0003
718 OPTIC NEURITIS 3 0.0003
719 JOINT INJURY 7 0.0003
720 IRRITABLE BOWEL SYNDROME 7 0.0003
721 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
722 NERVE COMPRESSION 3 0.0003
723 ABNORMAL WEIGHT GAIN 4 0.0003
724 HEART RATE INCREASED 32 0.0003
725 TENDONITIS 5 0.0003
726 CYST 4 0.0003
727 FLANK PAIN 3 0.0003
728 DYSPHAGIA 30 0.0003
729 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
730 STEVENS-JOHNSON SYNDROME 7 0.0003
731 ACUTE KIDNEY INJURY 48 0.0003
732 ABSCESS 5 0.0003
733 SENSORY DISTURBANCE 5 0.0003
734 AUTOIMMUNE DISORDER 3 0.0003
735 PLATELET COUNT INCREASED 4 0.0003
736 NEUTROPENIA 41 0.0003
737 JAUNDICE 8 0.0003
738 BLOOD GLUCOSE INCREASED 56 0.0003
739 HEPATIC FUNCTION ABNORMAL 11 0.0003
740 NEUTROPHIL COUNT INCREASED 3 0.0003
741 EUPHORIC MOOD 3 0.0003
742 ABNORMAL DREAMS 8 0.0003
743 PULMONARY HYPERTENSION 6 0.0003
744 PETECHIAE 3 0.0003
745 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
746 MASS 4 0.0003
747 MOUTH ULCERATION 6 0.0003
748 VISION BLURRED 39 0.0003
749 MENSTRUATION DELAYED 3 0.0003
750 RESTLESS LEGS SYNDROME 5 0.0003
751 ASPIRATION 3 0.0003
752 THROMBOSIS 22 0.0003
753 RESTLESSNESS 10 0.0003
754 NEOPLASM MALIGNANT 18 0.0003
755 PULMONARY MASS 4 0.0003
756 PHOTOPHOBIA 5 0.0003
757 OSTEOPENIA 4 0.0003
758 DERMATITIS CONTACT 3 0.0003
759 INTERNAL HAEMORRHAGE 3 0.0003
760 DIZZINESS 130 0.0003
761 LOWER LIMB FRACTURE 5 0.0003
762 THYROID DISORDER 4 0.0003
763 DELUSION 4 0.0003
764 BLOOD PRESSURE INCREASED 38 0.0002
765 TACHYCARDIA 22 0.0002
766 BLOOD POTASSIUM INCREASED 4 0.0002
767 BRADYCARDIA 13 0.0002
768 PRODUCT DOSE OMISSION ISSUE 72 0.0002
769 ASTHENIA 92 0.0002
770 ARTHRITIS 19 0.0002
771 COAGULOPATHY 4 0.0002
772 CHILLS 28 0.0002
773 ABDOMINAL PAIN LOWER 6 0.0002
774 PSYCHOTIC DISORDER 7 0.0002
775 HAEMATEMESIS 6 0.0002
776 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 4 0.0002
777 INTENTIONAL OVERDOSE 15 0.0002
778 HYPOACUSIS 10 0.0002
779 LACRIMATION INCREASED 7 0.0002
780 HIATUS HERNIA 3 0.0002
781 AMNESIA 15 0.0002
782 EYE PAIN 13 0.0002
783 OFF LABEL USE 197 0.0002
784 PULMONARY OEDEMA 10 0.0002
785 TOOTHACHE 4 0.0002
786 PNEUMONITIS 6 0.0002
787 ACCIDENTAL OVERDOSE 8 0.0002
788 HIP FRACTURE 7 0.0002
789 HYPERTENSION 46 0.0002
790 HYPOKALAEMIA 10 0.0002
791 THINKING ABNORMAL 4 0.0002
792 THROMBOCYTOPENIA 24 0.0002
793 SOMNOLENCE 43 0.0002
794 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
795 INFLAMMATION 11 0.0002
796 EYE DISORDER 7 0.0002
797 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
798 GASTRIC ULCER 4 0.0002
799 IMPAIRED QUALITY OF LIFE 3 0.0002
800 MUSCLE SPASMS 38 0.0002
801 ERUCTATION 4 0.0002
802 MENTAL IMPAIRMENT 5 0.0002
803 HAEMORRHOIDS 4 0.0002
804 CHOKING 4 0.0002
805 ENCEPHALOPATHY 5 0.0002
806 RENAL FAILURE 27 0.0002
807 CARDIAC DISORDER 19 0.0002
808 CARDIOMYOPATHY 3 0.0002
809 HAEMATOCRIT DECREASED 4 0.0002
810 BLOOD PRESSURE ABNORMAL 4 0.0002
811 PULMONARY EMBOLISM 19 0.0002
812 SYNCOPE 20 0.0002
813 PREGNANCY 4 0.0002
814 HEART RATE DECREASED 7 0.0002
815 APHASIA 6 0.0002
816 ARTHROPATHY 11 0.0002
817 LYMPHADENOPATHY 7 0.0002
818 HIP ARTHROPLASTY 3 0.0002
819 PHARYNGEAL OEDEMA 3 0.0002
820 LYMPHOMA 3 0.0002
821 ACUTE MYELOID LEUKAEMIA 3 0.0002
822 DYSGEUSIA 14 0.0002
823 METABOLIC ACIDOSIS 6 0.0002
824 LOSS OF CONSCIOUSNESS 24 0.0002
825 FEAR 5 0.0002
826 CONFUSIONAL STATE 30 0.0002
827 MUSCLE TIGHTNESS 3 0.0002
828 PAIN 113 0.0002
829 SEPTIC SHOCK 8 0.0002
830 BLOOD CREATININE INCREASED 12 0.0002
831 HAEMORRHAGE 19 0.0002
832 ANAPHYLACTIC REACTION 10 0.0002
833 VISUAL ACUITY REDUCED 6 0.0002
834 LIP SWELLING 6 0.0002
835 FEELING COLD 5 0.0002
836 FEELING HOT 11 0.0002
837 PALPITATIONS 21 0.0002
838 THERAPY NON-RESPONDER 8 0.0002
839 FACE OEDEMA 3 0.0002
840 FLUID RETENTION 9 0.0002
841 CONTUSION 17 0.0002
842 PAIN IN JAW 5 0.0002
843 DRUG INTOLERANCE 17 0.0002
844 PRODUCT AVAILABILITY ISSUE 4 0.0002
845 PANCREATIC CARCINOMA 5 0.0002
846 ECZEMA 9 0.0002
847 UNEVALUABLE EVENT 13 0.0002
848 BONE PAIN 10 0.0002
849 OSTEOPOROSIS 7 0.0002
850 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
851 LABORATORY TEST ABNORMAL 5 0.0002
852 TREMOR 28 0.0002
853 OCULAR HYPERAEMIA 8 0.0002
854 COMA 8 0.0002
855 PRODUCT PRESCRIBING ERROR 4 0.0002
856 THERAPY INTERRUPTED 12 0.0002
857 GOUT 3 0.0002
858 DIABETIC KETOACIDOSIS 4 0.0002
859 ARTHRALGIA 69 0.0002
860 NEURALGIA 4 0.0002
861 OEDEMA PERIPHERAL 20 0.0002
862 BACK PAIN 38 0.0002
863 EYE SWELLING 6 0.0002
864 VAGINAL HAEMORRHAGE 7 0.0002
865 COLITIS 6 0.0002
866 BLOOD URINE PRESENT 3 0.0002
867 HYPOTHYROIDISM 5 0.0002
868 FALL 52 0.0002
869 RENAL IMPAIRMENT 13 0.0002
870 LACTIC ACIDOSIS 5 0.0002
871 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
872 SPEECH DISORDER 8 0.0002
873 JOINT STIFFNESS 4 0.0002
874 DISABILITY 3 0.0002
875 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
876 DISORIENTATION 6 0.0002
877 EXPIRED PRODUCT ADMINISTERED 5 0.0002
878 DRUG INEFFECTIVE 196 0.0001
879 PRODUCT ADMINISTRATION ERROR 3 0.0001
880 VERTIGO 9 0.0001
881 DISCOMFORT 9 0.0001
882 URINARY TRACT INFECTION 25 0.0001
883 SKIN LESION 4 0.0001
884 MENTAL STATUS CHANGES 4 0.0001
885 DERMATITIS 3 0.0001
886 PANCYTOPENIA 8 0.0001
887 WITHDRAWAL SYNDROME 6 0.0001
888 KNEE ARTHROPLASTY 3 0.0001
889 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
890 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
891 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
892 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
893 INTENTIONAL PRODUCT MISUSE 12 0.0001
894 UNDERDOSE 10 0.0001
895 MELAENA 3 0.0001
896 PAIN IN EXTREMITY 40 0.0001
897 ORAL PAIN 3 0.0001
898 NERVOUSNESS 7 0.0001
899 PRURITUS 50 0.0001
900 LIMB DISCOMFORT 4 0.0001
901 COGNITIVE DISORDER 6 0.0001
902 SWELLING 12 0.0001
903 NERVOUS SYSTEM DISORDER 4 0.0001
904 HAEMOGLOBIN DECREASED 13 0.0001
905 CYSTITIS 4 0.0001
906 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
907 NECK PAIN 7 0.0001
908 LOCALISED INFECTION 3 0.0001
909 PRESYNCOPE 3 0.0001
910 NO ADVERSE EVENT 22 0.0001
911 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
912 SKIN DISORDER 4 0.0001
913 POLLAKIURIA 5 0.0001
914 EYE PRURITUS 4 0.0001
915 FLUSHING 12 0.0001
916 DIPLOPIA 3 0.0001
917 MUSCULOSKELETAL PAIN 6 0.0001
918 PARAESTHESIA 18 0.0001
919 ANHEDONIA 3 0.0001
920 CEREBRAL HAEMORRHAGE 4 0.0001
921 DRUG EFFECT DECREASED 6 0.0001
922 SKIN DISCOLOURATION 5 0.0001
923 DIVERTICULITIS 3 0.0001
924 DEEP VEIN THROMBOSIS 7 0.0001
925 JOINT SWELLING 13 0.0001
926 BREAST CANCER 10 0.0001
927 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
928 MUSCULAR WEAKNESS 12 0.0001
929 DYSSTASIA 3 0.0001
930 MUSCULOSKELETAL STIFFNESS 9 0.0001
931 CELLULITIS 5 0.0001
932 PLEURAL EFFUSION 6 0.0001
933 PERIPHERAL SWELLING 15 0.0001
934 GYNAECOMASTIA 3 0.0001
935 CARDIAC ARREST 8 0.0001
936 PRODUCT USE ISSUE 18 0.0001
937 HYPOAESTHESIA 14 0.0001
938 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
939 IMPAIRED HEALING 3 0.0001
940 EMOTIONAL DISTRESS 11 0.0001
941 GAIT INABILITY 3 0.0001
942 COLITIS ULCERATIVE 4 0.0001
943 ADVERSE DRUG REACTION 8 0.0001
944 BLISTER 5 0.0001
945 HYPONATRAEMIA 5 0.0001
946 TREATMENT FAILURE 7 0.0001
947 COMPLETED SUICIDE 7 0.0001
948 CEREBROVASCULAR ACCIDENT 14 0.0001
949 STOMATITIS 5 0.0001
950 DYSURIA 3 0.0001
951 BALANCE DISORDER 7 0.0001
952 LEUKOPENIA 4 0.0001
953 DYSARTHRIA 3 0.0001
954 HALLUCINATION 6 0.0001
955 ANAEMIA 15 0.0001
956 ERYTHEMA 16 0.0001
957 PLATELET COUNT DECREASED 8 0.0001
958 HYPOTENSION 15 0.0001
959 OEDEMA 4 0.0001
960 HAEMATOCHEZIA 4 0.0001
961 ATRIAL FIBRILLATION 7 0.0001
962 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
963 INJURY 5 0.0001
964 OSTEOARTHRITIS 3 0.0001
965 INCORRECT DOSE ADMINISTERED 16 0.0001
966 DEVICE DISLOCATION 3 0.0001
967 PRODUCT STORAGE ERROR 6 0.0001
968 OVERDOSE 14 0.0001
969 ARRHYTHMIA 3 0.0001
970 DISEASE RECURRENCE 3 0.0001
971 MULTIPLE SCLEROSIS 3 0.0001
972 GAIT DISTURBANCE 12 0.0001
973 CARDIAC FAILURE 5 0.0001
974 FEBRILE NEUTROPENIA 4 0.0001
975 BLOOD PRESSURE DECREASED 4 0.0001
976 DRY SKIN 8 0.0001
977 SKIN EXFOLIATION 5 0.0001
978 BURNING SENSATION 4 0.0001
979 ADVERSE EVENT 5 0.0001
980 MEDICATION ERROR 3 0.0001
981 CHRONIC KIDNEY DISEASE 4 0.0001
982 HERPES ZOSTER 3 0.0001
983 DRY MOUTH 4 0.0000
984 INJECTION SITE REACTION 3 0.0000
985 DISEASE PROGRESSION 5 0.0000
986 NEUROPATHY PERIPHERAL 4 0.0000
987 MOBILITY DECREASED 3 0.0000
988 TOXICITY TO VARIOUS AGENTS 7 0.0000
989 MYOCARDIAL INFARCTION 7 0.0000
990 CARDIAC FAILURE CONGESTIVE 3 0.0000
991 RHEUMATOID ARTHRITIS 4 0.0000
992 PSORIASIS 4 0.0000
993 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000